Leonard M. Greenstein's most recent trade in Carlsmed Inc was a trade of 71,429 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on July 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carlsmed Inc | Leonard M. Greenstein | CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 71,429 | 155,102 | - | - | Stock Options (Right to Buy) | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 20 Apr 2023 | 5,000 | 26,785 | - | 14.0 | 70,100 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.15 per share. | 21 Mar 2023 | 346 | 31,785 | - | 12.2 | 4,204 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 21 Mar 2023 | 332 | 32,131 | - | 12.6 | 4,196 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 21 Mar 2023 | 326 | 32,463 | - | 12.9 | 4,202 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 17 Mar 2023 | 333 | 32,789 | - | 12.6 | 4,199 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 17 Mar 2023 | 316 | 33,122 | - | 13.3 | 4,196 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 15 Mar 2023 | 5,000 | 33,438 | - | 13.4 | 67,200 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,462 | 38,751 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 4,462 | 13,388 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 15 Mar 2023 | 313 | 38,438 | - | 13.4 | 4,204 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 40,097 | 40,097 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 27,160 | 27,160 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 16 Feb 2023 | 5,000 | 34,289 | - | 15.1 | 75,600 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 19 Jan 2023 | 5,000 | 39,289 | - | 14.6 | 72,800 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.64 per share. | 15 Dec 2022 | 5,000 | 44,289 | - | 14.6 | 73,200 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.54 per share. | 17 Nov 2022 | 5,000 | 49,289 | - | 16.5 | 82,700 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.90 per share. | 20 Oct 2022 | 4,877 | 54,412 | - | 15.9 | 77,544 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.62 per share. | 20 Oct 2022 | 123 | 54,289 | - | 16.6 | 2,044 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 15 Sep 2022 | 5,000 | 59,289 | - | 16.0 | 80,150 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 18 Aug 2022 | 5,000 | 64,289 | - | 16.3 | 81,500 | Common Stock |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 60,846 | 60,846 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 17,850 | 17,850 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Leonard M. Greenstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 40,999 | 40,999 | - | - | Stock Option (right to buy) |